Company: RNAC
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001453687-25-000075
Chunk: 47

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 47
---
, 2024. In connection with the Merger, the Compensation Committee of the Board approved the acceleration of the payment of each Retention Bonus, each of which was paid shortly following the closing of the Merger, pursuant to retention bonus letters with each Retention Bonus recipient, provided that each Retention Bonus recipient was required to repay his Retention Bonus in the event that he or she ceased to provide services to the Company prior to June 30, 2024, unless the recipient’s termination was due to an involuntary termination of all of the recipient’s services by the Company without cause.

#### Executive Compensation Practices
We endeavor to maintain sound executive compensation policies and practices, including compensation-related corporate governance standards, consistent with our executive compensation philosophy. During 2024, the following executive compensation policies and practices were in place, including both policies and practices we have implemented to drive performance and policies and practices that either prohibit or minimize behaviors that we do not believe serve our stockholders’ long-term interests:

<div align='center'>27</div>

What We Do

| ü |     | Compensation Committee Independence– Our Board maintains a Compensation Committee comprised solely of independent directors who have established effective means for communicating with our stockholders regarding their executive compensation ideas and concerns.                                                                                                                |
| ü |     | Compensation Committee Advisor Independence– The Compensation Committee engages and retains its own advisors. In 2024, the Compensation Committee re-engaged Compensia as compensation consultant to assist with its responsibilities. Compensia performs no consulting or other services for the Company.                                                                         |
| ü |     | Annual Compensation Review– The Compensation Committee conducts an annual review of our executive compensation philosophy and strategy, including a review of the compensation peer group used for comparative purposes.                                                                                                                                                           |
| ü |     | Compensation-Related Risk Assessment– We conduct an annual evaluation of our compensation programs, policies, and practices to ensure that they reflect an appropriate level of risk-taking but do not encourage our employees to take excessive or unnecessary risks that could have a material adverse impact on our Company.                                                    |
| ü |     | Emphasize Long-Term Equity Compensation– The Compensation Committee uses equity awards to deliver long-term incentive compensation opportunities to our executive officers, including our Named Executive Officers. These equity awards vest or may be earned over multi-year periods, which we believe better serves our long-term value creation goals and retention objectives. |
| ü |     | Limited Executive Perquisites– We provide only modest amounts of perquisites or other personal benefits that serve a sound business purpose to the Named